ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

PatientNow Acquires Recura, the AI Growth Engine Powering Practice Growth

By: PRLog
PatientNow, the leader in practice management and growth technology for aesthetics practices, today announced the acquisition of Recura, an AI-powered growth engine designed to help practices capture, convert, and grow like never before.

NEW YORK - Oct. 29, 2025 - PRLog -- PatientNow has spent years as the market leader helping its customers achieve their number one goal: revenue growth. Today, their acquisition of Recura dramatically accelerates that commitment.

Recura acts as a full-time sales team, receptionist, and booking coordinator, all in one. It's on 24/7, instantly responding via voice and text to every call, message, and form submission. By converting inquiries into booked appointments, Recura ensures no opportunity goes unanswered.

Practices using Recura are already seeing transformational results, with one turning 48-hour follow-ups into 30-second responses, another driving $10,000 in additional revenue in one month by eliminating missed calls, and another generating 86 ready-to-book customers in a single day.

"PatientNow combined with Recura represents the future of growth for aesthetics practices," said Keri Gohman, CEO of PatientNow. "By combining PatientNow's industry-leading platforms with Recura's AI-driven capabilities, we're giving our customers a 24/7 growth engine that never stops working."

Customers of PatientNow can enjoy an exclusive, deep integration with Recura, allowing clients to book, reschedule, and cancel through the platform. Plus, practices will soon be able to run targeted campaigns automatically to fill their calendars, process payments seamlessly, and optimize revenue and retention using insights unique to their business.

Gohman added, "This is the start of a new era of innovation for PatientNow, which you'll see start to come to life in our new look and feel that launched today."

"Recura has always been focused on helping make our clients more money. Partnering with PatientNow allows us to scale our mission at lightspeed and expand to new practices," said Harrison Cuker CEO and Co-founder of Recura.

Cuker added, "Inside of PatientNow, we're delivering the transformation from a system of record to a system of action as the true market leader."

Recura will continue to operate as a standalone business, continuing to sell directly to non-PatientNow customers, focusing on delivering industry-leading growth solutions, as well as powering innovation for PatientNow and supporting its existing customers and both new and existing integrations.

About PatientNow

Designed for beauty, built for growth, PatientNow is designed to keep medical aesthetics and elective care practices in perfect proportion. Intelligent automation for the repeatable, insights for the essential, space for our clients' artistry, and powerful tools to drive growth.

From EMR and CRM to marketing automation and analytics, PatientNow delivers a connected platform that helps practices attract, convert, and retain more patients, while elevating the client experience at every touchpoint.

Media Contact
James O'Connell-Cooper
jamesoc@patientnow.com

Photos: (Click photo to enlarge)

PatientNow Logo


Source: PatientNow

Read Full Story - PatientNow Acquires Recura, the AI Growth Engine Powering Practice Growth | More news from this source

Press release distribution by PRLog

Recent Quotes

View More
Symbol Price Change (%)
AMZN  227.35
+0.59 (0.26%)
AAPL  273.67
+1.48 (0.54%)
AMD  213.43
+12.37 (6.15%)
BAC  55.27
+1.01 (1.86%)
GOOG  308.61
+4.86 (1.60%)
META  658.77
-5.68 (-0.85%)
MSFT  485.92
+1.94 (0.40%)
NVDA  180.99
+6.85 (3.93%)
ORCL  191.97
+11.94 (6.63%)
TSLA  481.20
-2.17 (-0.45%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.